HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides.

Abstract
A case report has suggested that exposure to erythromycin through breast milk might cause infantile hypertrophic pyloric stenosis. This study therefore examined whether macrolides, transmitted via breast milk, increase the risk of infantile hypertrophic pyloric stenosis in neonates. A population-based cohort study was conducted, based on data from a prescription registry, the Danish Birth Registry and North Jutland County's hospital discharge registry, Denmark, and comprising 1166 pregnant women who had been prescribed macrolides from birth to 90 d postnatally, and 34,690-41,778 pregnant women as controls. The odds ratios for infantile hypertrophic pyloric stenosis varied between 2.3 and 3.0 according to different periods of postnatal exposure, and after stratification for gender they were 10.3 [95% confidence interval (95% CI) 1.2-92.3] for girls and 2.0 (95% CI 0.5-8.4) for boys. The use of macrolides during breast-feeding increases the risk of infantile hypertrophic pyloric stenosis.
AuthorsHenrik Toft Sørensen, Mette Vinther Skriver, Lars Pedersen, Helle Larsen, Finn Ebbesen, Henrik C Schønheyder
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 35 Issue 2 Pg. 104-6 ( 2003) ISSN: 0036-5548 [Print] England
PMID12693559 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Macrolides
Topics
  • Abnormalities, Drug-Induced (epidemiology, etiology)
  • Adult
  • Breast Feeding
  • Case-Control Studies
  • Confidence Intervals
  • Denmark (epidemiology)
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Logistic Models
  • Macrolides (adverse effects, therapeutic use)
  • Maternal Exposure (adverse effects)
  • Milk, Human (chemistry)
  • Odds Ratio
  • Postnatal Care
  • Pregnancy
  • Pyloric Stenosis (epidemiology, etiology)
  • Registries
  • Risk Assessment
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: